肿瘤系列三EGFRm肺癌
FRANKLIN TEMPLETON·2024-07-25 16:41
Key Points - Industry/Company Involved: EJR4I专题,西南医药 - Analyst: 刘潇,西南医药分析师 - Purpose of the Report: To provide an update on the EJR4I topic [1].
Key Points - Industry/Company Involved: EJR4I专题,西南医药 - Analyst: 刘潇,西南医药分析师 - Purpose of the Report: To provide an update on the EJR4I topic [1].